Ticker Details
Biofrontera Inc.
IPO Date:	October 29, 2021
Sector:	Healthcare
Industry:	Drug Manufacturers - Specialty and Generic
Market Cap:	$12.11M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.12 | 4.99%
Avg Daily Range (30 D):	$0.02 | 2.67%
Avg Daily Range (90 D):	$0.03 | 3.68%

Institutional Daily Volume
Avg Daily Volume:	1.29M
Avg Daily Volume (30 D):	.09M
Avg Daily Volume (90 D):	.27M

Trade Size
Avg Trade Size (Sh.):	235
Avg Trade Size (Sh.) (30 D):	327
Avg Trade Size (Sh.) (90 D):	273

Institutional Trades
Total Institutional Trades:	27
Avg Institutional Trade:	$1.17M
Avg Institutional Trade (30 D):	$2.12M
Avg Institutional Trade (90 D):	$2.12M
Avg Institutional Trade Volume:	.01M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$.74M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	4.51K

News

Dec 4, 2025 @ 2:00 PM Last Patient Completes Biofrontera’s Phase ... Source: Biofrontera Inc.

Aug 14, 2025 @ 7:01 PM Biofrontera Q2 Revenue Jumps 15% Source: Hermann Luebbert

Aug 13, 2025 @ 9:20 PM Biofrontera Inc. Reports Second Quarter 2025 Finan... Source: Hermann Luebbert

Aug 4, 2025 @ 6:00 PM Biofrontera Inc. to Report Second Quarter FY 2025 ... Source: Andrew Barwicki

Jun 11, 2025 @ 7:00 PM BIOFRONTERA INC. IS NEGOTIATING FUNDAMENTAL CHANGE... Source: N/A

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1.04	$.63	$-1.04
Diluted EPS	$-1.04	$.63	$-1.04
Revenue	$41.71M	$17.1M	$41.71M
Gross Profit
Net Income / Loss	$-10.54M	$5.64M	$-10.54M
Operating Income / Loss	$-11.35M	$4.56M	$-11.35M
Cost of Revenue
Net Cash Flow	$.49M	$2.98M	$.49M
PE Ratio

Splits
Jul 05, 2023	1:20